Jin Shi Shu Ju·2025-09-19 14:23Group 1 - Juewei Foods faces risk warning and will be labeled as "ST Juewei" due to disclosure violations, with trading suspension on September 22, 2025 [2] - Fosun Pharma's subsidiary has received EU approval for its osteoporosis treatment products, with projected global sales of approximately $7.463 billion in 2024 [3] - Tailin Microelectronics has achieved mass production of its edge AI chips, with sales reaching millions of RMB in Q2 2025 [3] Group 2 - Saiseng Pharma's major shareholder plans to reduce their stake by up to 2% within three months [4] - Zhongcheng Group's stake in Zhongcheng Co. has increased to 42.12% after transferring shares to Zhongji Import and Export [5] - Dingsheng Co. plans to transfer 4.82% of its shares through an inquiry-based method [6] Group 3 - Fudan Fuhua will be labeled as "ST Fuhua" starting September 23, 2025, due to regulatory warnings [7] - Huadian Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange [8] - New Jufeng's shareholders plan to reduce their stake by up to 4.5% [9] Group 4 - Watson Bio's subsidiary has received acceptance for clinical trials of its mRNA vaccine for shingles [10] - Jintou Chengkai is adjusting its major asset restructuring plan, which will not change the controlling shareholder [11] - Hangdian Co. has seen a significant stock price increase of 46.52% over four trading days, raising concerns about potential volatility [12] Group 5 - Shenli Co. plans to reduce its stake by up to 3% due to funding needs [13] - Xinwangda's subsidiary is investing 60 million RMB to establish a private equity fund focused on energy storage projects [14] - Fuxai Technology has set an initial transfer price of 72.08 RMB per share for its inquiry-based transfer [15] Group 6 - Jilin Aodong's subsidiary has received a drug registration certificate for a traditional Chinese medicine [16] - Tianpu Co. has experienced a 13-day stock price surge, raising concerns about potential rapid declines [17] - Zhongchu Co. is increasing its investment in Zhongchu Hengke by 84.3146 million RMB through debt-to-equity swaps [18] Group 7 - Wuzhou Transportation's major shareholder has secured a loan commitment of up to 153 million RMB for share buybacks [19] - Shanxi Fenjiu has elected a new chairman and vice-chairmen for its board [20] - Qujiang Cultural Tourism has confirmed normal operations amid stock price fluctuations [21] Group 8 - Sike Rui will be labeled as "ST Sike Rui" and suspended for one day due to regulatory warnings [22] - Anning Co. is applying for a 3 billion RMB syndicated loan for asset restructuring [23] - Anning Co. has completed a significant debt restructuring plan totaling approximately 192.669 billion RMB [27] Group 9 - China Chemical reported a total contract amount of 256.339 billion RMB from January to August 2025 [28] - Jishi Media has elected a new chairman [29] - Lingyun Optics has adjusted its share repurchase price limit to 52 RMB per share [30] Group 10 - Baoli International plans to invest in semiconductor testing equipment company Hongtai Technology [29] - Pinming Technology's stock will continue to be suspended for up to three additional trading days [30] - Ankai Micro plans to invest 20 million RMB for a 4% stake in Shiqi Future [30]